Blog: Depo-Provera Lawsuit
- Depo-Provera Lawsuits: Tracy Finken Magnotta Provides Update at HarrisMartin MDL CLE Conference on December 4
Nov 22, 2024
The status of the Depo-Provera meningioma lawsuits against Pfizer will be addressed by Anapol Weiss shareholder Tracy Finken Magnotta at the HarrisMartin MDL CLE Conference on Wednesday, December 4, in New York City. Magnotta and her team at Anapol Weiss filed one of the first lawsuits against Pfizer, alleging that the company failed to warn Depo-Provera users about the increased risk of developing meningioma tumors with prolonged use of the injectable contraceptive. Anapol Weiss is...Read More - A Guide to the History of Depo-Provera
Nov 21, 2024
Depo-Provera, a widely used injectable contraceptive, has a long and complex history of development, medical applications, and controversies. Initially hailed as a breakthrough in birth control, its use has been clouded by numerous studies and global debates about its safety. Recent developments, including a 2024 study linking long-term Depo-Provera use to an increased risk of meningiomas, have raised new questions about its safety. The Discovery of Medroxyprogesterone Acetate Depo-Provera’s active ingredient, medroxyprogesterone acetate (MPA), was first synthesized...Read More - U.S. News and The Guardian Report: Depo-Provera Associated with an Increased Risk of Tumors
Oct 28, 2024
The excerpts below from The Guardian and U.S. News provide essential information about the French study, announced in March 2024, that found an increased risk of brain and spinal cord tumors to be associated with prolonged Depo-Provera use. The study is referenced in Depo Provera brain tumor lawsuits filed against pharmaceutical manufacturer Pfizer. Anapol Weiss filed its first complaint against Pfizer on October 28, 2024, on behalf of a California woman who used Depo-Provera over...Read More - Anapol Weiss Files Depo Lawsuit Against Pfizer Over Alleged Meningioma Tumors Link
Oct 28, 2024
San Francisco, CA – October 28, 2024 – The law firm of Anapol Weiss, known nationally for its leadership in mass tort litigation, today announced the filing of a personal injury lawsuit on behalf of Kathleen Fazio, a 56-year-old California woman, against pharmaceutical giant Pfizer, Inc. The lawsuit, filed in the United States District Court for the Central District of California, alleges that Fazio developed an intracranial meningioma (brain tumor) as a result of her use...Read More - Depo-Provera Lawsuit Settlements 2024: Most Recent In a Long Line of Litigation Against Unsafe Birth Control Products
Oct 14, 2024
Birth control has been a revolutionary development for women’s reproductive health and autonomy. However, some forms of birth control have also come with serious risks, leading to a wave of lawsuits against manufacturers over the years. From the notorious Dalkon Shield in the 1980s to the more recent Depo-Provera litigation (related to the product’s increased risk of causing brain and spinal cord tumors), the legal landscape surrounding birth control devices and drugs has been fraught...Read More - A Lifetime of Legal Battles Against Dangerous Products
Oct 10, 2024
Tracy Finken Magnotta, Anapol Weiss Women’s Health Ligitation Team I Have Spent My Career Holding Companies Accountable for Marketing Unsafe Products and Failing to Disclose the Serious Risks to Consumers However, time and again, we see these companies prioritizing profits over safety. Billion-dollar products are marketed without proper warnings and the result is often catastrophic. Over the past 25 years, I have been passionate about representing women and children for the life-changing injuries they have sustained and...Read More - Depo Provera Long Term Side Effects & How to File a Lawsuit
Oct 9, 2024
Depo-Provera (medroxyprogesterone acetate), a long-acting contraceptive injection, is used by millions of women worldwide. While exact numbers can vary by region and over time, as of recent estimates: Global use: Around 20 million women worldwide have used Depo-Provera. United States: Approximately 1.6 million women use Depo-Provera in the U.S. annually. This accounts for about 3% of women using contraception in the country. Recent research has exposed serious Depo Provera long term side effects, giving rise to legal action...Read More - Pfizer and Depo-Provera: Another Example of a Company Failing to Warn Women About Risks in Products and Medicines
Oct 7, 2024
In recent years, there has been a growing awareness of how certain companies have failed to adequately warn female consumers about the risks associated with their products and medicines. From pharmaceuticals to cosmetics, several high-profile cases have highlighted the negligence of corporations in protecting women’s health. The most recent example is Pfizer’s failure to warn millions of users of Depo-Provera about the injection’s increased risk of causing brain and spinal cord tumors (meningiomas). When research revealed...Read More - Informed Consent and Depo-Provera: Are Women Being Properly Informed?
Oct 7, 2024
Women deserve the right to make choices about their health, but only through full and accurate warnings and drug information can any woman make the decision that’s right for her. Women who aren’t properly informed about the risks of their birth control medications could be taking on serious health risks without even knowing it. That, along with the severe harm that has been linked to birth control injections in the form of an increased risk...Read More - Depo Provera Shot Lawsuit: Law.com Interviews Anapol Weiss Shareholder Kila Baldwin
Oct 7, 2024
Published in Law.com Written By: Amanda Bronstad Kila Baldwin is one of the leaders of the Anapol Weiss Women’s Health Litigation Team. She is currently preparing Depo Provera shot lawsuit cases. By filing Depo Provera shot lawsuit complaints against Pfizer on behalf of women who have had brain or spinal cord tumors (meningiomas) and who were on Depo-Provera for a year or more, she and her colleagues are standing up for the rights and safety of women.] Excerpts...Read More